Methotrexate
Aus coViki
(Unterschied zwischen Versionen)
(Die Seite wurde neu angelegt: „ {{tp|p=32534807|t=2020. Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'P…“) |
|||
| (2 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) | |||
| Zeile 1: | Zeile 1: | ||
| + | {{up|PHA conventional pharmacology}} | ||
| + | {{up|JAK Janus Kinase}} | ||
| + | {{tp|p=32454489|t=2020. JAK Inhibition with Methotrexate as Treatment for COVID-19 Is a Double-Edged Sword.|pdf=|usr=007}} | ||
{{tp|p=32534807|t=2020. Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'PANIC' attack.|pdf=|usr=008}} | {{tp|p=32534807|t=2020. Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'PANIC' attack.|pdf=|usr=008}} | ||
{{ttp|p=32471659|t=2020. Silencing of immune activation with methotrexate in patients with COVID-19.|pdf=|usr=008}} | {{ttp|p=32471659|t=2020. Silencing of immune activation with methotrexate in patients with COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32535597|t=2020. Combination of JAKinibs with Methotrexate or Anti-Cytokine Biologics in Patients with Severe COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32880032|t=2020. Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates.|pdf=|usr=018}} | ||
| + | {{tp|p=32926453|t=2020. Methotrexate inhibits SARS-CoV-2 virus replication "in vitro".|pdf=|usr=019}} | ||
| + | {{tp|p=C7334116|t=2020. Etanercept/methotrexate: COVID-19: case report.|pdf=|usr=015}} | ||
Aktuelle Version vom 11. April 2021, 19:53 Uhr
| PHA conventional pharmacology |
| JAK Janus Kinase |
32454489 2020. JAK Inhibition with Methotrexate as Treatment for COVID-19 Is a Double-Edged Sword.
32534807 2020. Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'PANIC' attack.
| 32471659 2020. Silencing of immune activation with methotrexate in patients with COVID-19. |
32535597 2020. Combination of JAKinibs with Methotrexate or Anti-Cytokine Biologics in Patients with Severe COVID-19.
32880032 2020. Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates.
32926453 2020. Methotrexate inhibits SARS-CoV-2 virus replication "in vitro".
C7334116 2020. Etanercept/methotrexate: COVID-19: case report.
